SIGE clinical trials

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

This study is testing a new medicine, amlitelimab, for adults with coeliac disease that isn't getting better with a gluten-free diet. It looks at how well the medicine works and if it's safe, by checking changes in the gut and how people feel.